AI Risks · Toronto biotech secures $2.2M to treat immune diseases

CIFAR leader expects CAISI to help inform AI policy in Canada and abroad | Beta Kit

With its new AI safety institute, Canada aims to study the technology'srisksand collaborate with other countries …

Read the original at Toronto biotech secures $2.2M to treat immune diseases ↗

Topics
Regulation & PolicyAI Safety & Existential RiskJobs & the Economy
Mentions
Canada
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”